Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea
Post-marketing surveillance study assessing safety and efficacy of Inlyta in South Korea for advanced renal cell carcinoma; study completed …
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery [NA]
Clinical trial update for adaptive staged stereotactic body radiation therapy in patients with spinal metastases, completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer [Phase 2]
A Phase 2 clinical trial evaluating a monoclonal antibody therapy for advanced kidney cancer (renal cell carcinoma) has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma [Phase 2]
This Phase 2 trial evaluating NIR178 in combination with PDR001 across multiple solid tumors and non-Hodgkin lymphoma was terminated, with r…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: A Study of Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013) [Phase 2]
Phase 2 study of belzutifan (MK-6482) in participants with advanced renal cell carcinoma; results have been posted and the trial is currentl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment [Phase 3]
Phase 3 study comparing atezolizumab plus cabozantinib versus cabozantinib alone in advanced renal cell carcinoma after prior immune checkpo…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types [Phase 2]
Phase 2 trial update reporting access to nivolumab for adults with selected rare cancer types; study completed.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors [Phase 2]
Phase 2 trial evaluating checkpoint inhibition in combination with external beam radiotherapy for solid tumors; study is completed.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease
A terminated clinical trial exploring mechanisms and predictors of hypertension and cardiovascular disease associated with VEGF receptor inh…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)
Retrospective study evaluating first-line treatment with avelumab plus axitinib in Japanese renal cell carcinoma patients; results posted af…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma [Phase 1]
Phase 1 trial assessing trigriluzole in combination with nivolumab and pembrolizumab for various metastatic or unresectable solid tumors and…
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: MRI Study of BAY 43-9006 in Metastatic Renal Cell Carcinoma [Phase 3]
Phase 3 MRI study update of BAY 43-9006 in metastatic renal cell carcinoma has been completed.
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults [Phase 4]
Phase 4 clinical trial update assessing optimal dosing of oral anticancer drugs in older adults, with multiple cancer indications listed.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the combination of pucotenlimab and lenvatinib as neoadjuvant therapy for non-clear cell renal cell carcin…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients
A completed prospective observational analysis evaluating complete remission in renal cell carcinoma patients treated with sunitinib.
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update for HBI-8000 in combination with nivolumab across melanoma, renal cell carcinoma, and non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating the combination of pembrolizumab and cabozantinib (Cabometyx) in patients with metastatic renal cell …
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Phase II Study of Alternating Sunitinib and Temsirolimus [Phase 2]
Phase II study evaluating alternating sunitinib and temsirolimus in metastatic renal cell carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) [Phase 2]
Phase 2 trial evaluating niraparib in BAP1- and DDR-deficient neoplasms including mesothelioma and uveal melanoma has completed with results…
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: High Dose IL 2 and Entinostat in RCC [Phase 2]
Phase 2 clinical trial evaluating high-dose IL-2 and entinostat in Renal Cell Carcinoma is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Efficacy of PErioperative PEmbrolizumab Treatment in Patients With Resectable Metastases From Kidney Cancer [Phase 2]
A Phase 2 clinical trial update evaluating perioperative pembrolizumab for patients with resectable oligometastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: PET/MR Characterization of Renal Cell Carcinomas [NA]
Clinical trial update on PET/MR characterization of renal cell carcinoma; study terminated with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma [Phase 1]
Phase 1 trial of APX005M in combination with nivolumab and cabiralizumab in advanced melanoma, non-small cell lung cancer, and renal cell ca…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating IPI-549 in combination with front-line therapies for triple-negative breast cancer or renal cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy [Phase 3]
Phase 3 trial of atezolizumab as adjuvant therapy for high-risk renal cell carcinoma after nephrectomy was terminated; results posted in 202…